(Q36680092)

15 August 2017

Antituberculosis treatment-induced hepatotoxicity: role of predictive factors (English)

1 reference

15 August 2017

1 reference

J Singh

1

1 reference

15 August 2017

A Arora

2

1 reference

15 August 2017

P K Garg

3

1 reference

15 August 2017

V S Thakur

4

1 reference

15 August 2017

J N Pande

5

1 reference

15 August 2017

R K Tandon

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

Postgraduate Medical Journal

15 August 2017

1 reference

15 August 2017

71

1 reference

15 August 2017

836

1 reference

15 August 2017

359-362

1 reference

Hepatotoxicity of antituberculous drugs

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Toxic hepatitis with isoniazid and rifampin. A meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Drug treatment of tuberculosis--1992

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Isoniazid-associated hepatitis in 114 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

The hepatic toxicity of antituberculosis regimens containing isoniazid, rifampicin and pyrazinamide

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Sulphadimidine Acetylation Test for Classification of Patients as Slow or Rapid Inactivators of Isoniazid

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Isoniazid prophylaxis in hepatitis B carriers

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Isoniazid-rifampin-induced hepatitis in hepatitis B carriers

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Hepatitis and antitubercular therapy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Hepatitis in patients with surgical complications of pulmonary tuberculosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Hepatitis cases in isoniazid treated groups and in a control group

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Isoniazid pharmacokinetics in kwashiorkor

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Anti tubercular treatment induced hepatotoxicity: does acetylator status matter?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2398146

Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis

5 September 2018

1 reference

12 December 2020

Lack of relationship between hepatic toxicity and acetylator phenotype in three thousand South Indian patients during treatment with isoniazid for tuberculosis

1 reference

12 December 2020

Hepatotoxicity of isoniazid and rifampin in children

1 reference

12 December 2020

Isoniazid, rifampin, and hepatotoxicity

1 reference

12 December 2020

Hepatic toxicity in South Indian patients during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin and pyrazinamide

1 reference

12 December 2020

Study on hepatotoxicity and other side-effects of antituberculosis drugs

1 reference

12 December 2020

Hepatotoxicity of rifampin and isoniazid. Is it all drug-induced hepatitis?

1 reference

12 December 2020

The use of pyrazinamide plus isoniazid in the treatment of pulmonary tuberculosis

1 reference

12 December 2020

Effect of Rifampicin and Isoniazid on Liver Function

1 reference

12 December 2020

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites

1 reference

12 December 2020

Identifiers

DOI

10.1136/PGMJ.71.836.359

1 reference

15 August 2017

1 reference

15 August 2017

1 reference